Duncan Crow
Wholistic Consultant

Metabolic Enzymes Reduce Heart Attack and Stroke


  • The biggest cause of heart disease, peripheral arterial disease and stroke is excessive blood coagulation and fibrosis.
  • The biggest cause of kidney disease is also fibrosis, the hallmark of which is inflammation, excessive scarring, and fibrin deposits.
Blockages can be avoided and circulation improved by supplementing to prop falling levels of plasmin, your body's only fibrinolytic enzyme. The cure is sweet and simple.

Fibrinolytic Enzyme References


The company has many good products. If phoning in your order you get 10% off; PLEASE quote referral ID 1070 in Canada and USA, 1559 in the UK.

Medicine manages the thickening blood and inflammation associated with coagulopathy with blood thinners that carry a bleeding risk that is so serious that, according to research, a "poor prognosis" will result in the event of a haemorrhagic stroke.

Medicine manages growing arterial blockages with sporadic cleaning, stents, heart bypass surgery, and limb amputations.

Obviously medicine knows of no cure, no reversal of the disorder.

However, a non-medical technique that simply addresses the cause, low plasmin and high inflammation, is known to improve circulation considerably.

More than 20 enzymes are involved in the clot-creating coagulation cascade, but just one –- plasmin -– dissolves fibrin, the clotting protein, which erodes clots and allows coagulating blood to circulate more easily. Unfortunately plasmin decreases with age, and this allows fibrin levels to rise and present a serious risk of heart attack or stroke.

The Drug Approach to Clots

Thrombolytic, or clot-busting, drugs on one hand can be used in the early treatment of many heart attack patients, but even when properly administered the drugs kill three in every 1,000 patients by making them bleed to death. Even with caution they are not useful for maintenance.

Warfarin and Coumadin-type drugs on the other hand work by interfering with natural coagulation as well as excessive coagulation. The therapeutic window is very small, and highish dose produces increased bleeding; even at the correct dose there is increased bleeding from minor wounds, increased oxidative stress due to chronic hemoglobin leakage, and also the aforementioned elevated stroke risk with its poor prognosis, which becomes statistical even if the patient has been on warfarin (or aspirin) for only 3 months.

The Non-Drug Approach to Clots

The non-drug approach instead uses certain metabolic (systemic) enzymes, so called because they work in regular metabolism. In this case they are called fibrinolytic enzyme because they have the same clot-busting property of fibrin digestion that natural plasmin does. Fibrin is the first stage of clotting, and it's supposed to be continually eroded as it's not needed. Fibrinolytic enzymes dissolve clot material without interfering natural coagulation, and they also reduce excess thickening of the blood by the same mechanism. There is little or no bleeding risk and no interference at all with wound healing.

Nattokinase (NK) is in the family of oral fibrinolytic enzymes; the best fibrinolytic metabolic enzyme discovered, it is four times as effective than plasmin at dissolving fibrin directly, and studies indicate it may also enhance the body's own production of plasmin.

When used on an empty stomach Nattokinase and a few others are effective in a variety of conditions involving fibrotic conditions, such as in adhesions and scar tissue from surgery or injury. In fact in Japan in its raw form as Natto, a garnish, it's been used for millennia for these properties. Nattokinase is more potent and economically feasible than any current clot buster including urokinase, so here you have something that’s backed by research that shows it would work in stroke, angina, venous stasis, thrombosis emboli, atherosclerosis, fibromyalgia, fatigue, claudication, retinal pathology, hypertension, diabetes, deep vein thrombosis and arterial embolism”, says Garry Gordon, whom some call the Genius of Complementary Medicine.

I have selected (10/2005) a new blend BlockBuster All Clear as a superior and cost competitive formula. that contains the most potent, standard nattokinase NSK-SD™.

Nattokinase has been shown to lower systolic blood pressure by up to 11% and diastolic pressure by up to 9.7% in those who needed it. In fact it is a safe and viable preventive anti-clotting blood thinner that can substitute for warfarin (Coumadin) or daily aspirin for patients. Any health-conscious individual who wishes to use a natural therapy to prevent unnecessary blood clotting and reduce inflammation can use it. Though hemophiliacs and borderline hemophiliacs should be cautious, no incidents of the blood getting too thin have been reported with any enzyme including nattokinase. Though experts agree that NK is remarkably safe and virtually non-toxic for use by people who are not already using anticoagulant-type drugs, if patients already are using warfarin, heparin or other anticoagulants their dosage will be necessarily reduced by your doctor. If you use enzymes you can continue to use supplements that help keep platelets “slippery” or reduce inflammation, such as omega 3 oils, garlic, ginkgo biloba, or vitamin E.

Research is validating the clinically-seen effect that enzymes keep stents open longer and improve both clogged arterial and micro-circulation. Many diabetics have avoided limb amputation when clots and plaque were removed and full circulation was restored in as little as 48 hours by several enzymes including serrapeptase, also called serratia peptidase, which has been shown to induce intense clot busting, anti-inflammatory and anti-edemic activity. As inflammation increases fibrinogen levels and increased fibrinogen increases clotting risk, the powerful anti-inflammatory activity of serrapeptase nicely complements the excellent clot busting activity of nattokinase.

I have selected BlockBuster All Clear because it's powerful and inexpensive; it contains the most potent, standard nattokinase NSK-SD™ as well as serrapeptase and Seaprose S. I'll get back to that in the next section.

Metabolic enzymes for endometriosis, fibroids and adhesions


Metabolic enzymes are unsurpassed for safely dissolving fibrosis and adhesions. In fact, no other remedy has this ability. Fibromyalgia patients would be impressed to learn the therapy does not discriminate between fibrosis and arterial blockages, but the therapy should interest everyone of both sexes.



Fibrinolytic Enzyme References


This subject is of general interest because after about age 27 or so EVERYONE experiences a reduced output of anti-clotting enzymes, so tissues begin to lose their elasticity and organs begin to shrink, harden and reduce function as fibrosis begins to accumulate. Fibrosis is the leading cause of organ failure in aging, and enzyme therapy to reduce this occurrence represents a very powerful ounce of prevention that makes tissues, organs and arteries more resilient, less blocked and more functional again in a very short time.

A diagram of adhesions, online here, comes with the description, Adhesions are strands of scar tissue that form in response to abdominal surgery and extend beyond the specific site of incision. Scar tissue that mends the incision is normal, but the adhesions form additionally under some circumstances that are not fully understood.

How adhesions are formed may not be fully researched, but we know they occur particularly in older patients who do not have enough enzymes to dissolve the fibrin, and we also know that peer-reviewed journals have contained information on preventing and dissolving adhesions and scars for quite some time. The prevention of peritoneal adhesions by papain was published in Annals of Surgery in 1936, Use of papase in prevention of experimental peritoneal adhesions came up in 1969 in Surgery, Bromelain therapy for the prevention of episiotomy pain appeared in Obstetrics and Gynecology in 1967, and a study called Plant enzymes in oral surgery appeared in Oral Surgery in 1965. Papain and other digestive enzymes have been used to treat ulcers, dissolve membranes in diphtheria, and reduce swelling, fever and adhesions after surgery for about 50 years all told, and it's commonly accepted that protein-digesting enzymes reduce fibrosis with no side effects. These earlier attempts used enzymes that are not particularly good at it; the new develpment is the discovery and application of enzymes that do it better.

Dr. Chris Serafini says in an article titled Neprinol and Endometriosis, "The (oral) enzymes in Neprinol work swiftly to break apart fibroids, improve circulation, stimulate the immune system, and reduce inflammation. Neprinol's two foremost ingredients (Serrapeptase and Nattokinase) help remove fibroids by dissolving the fibrous part of the fibroid tumor. Clinical studies have shown that Serrapeptase and Nattokinase work fast and effectively to dissolve fibrin safely with no adverse side effects. Neprinol is extremely effective at removing toxins from the bloodstream, and then helping to pass the emulsified fibrous tissue. Fibrin and inflammation remain consistent among patients that have fibroids, arthritis, heart disease, and several other diseases."

That being said, Neprinol is old school and the formula has been improved on. The widely used test that measures fibrolytic units (FU), gives a positive result for practically all of the protein-digesting enzymes including those that do not dissolve fibrin very well, such as the protease in Neprinol. The more accurate ELISA test reveals the difference, that only one nattokinase, NSK-SD™, matches the molecular structure of the original discovery, and it is the only nattokinase that is endorsed by Dr. Sumi, the discoverer, and Dr. Holsworth, the leading U.S. researcher, of nattokinase.


Why BlockBuster AllClear should replace warfarin/coumadin


While warfarin carries a bleeding risk and resulting poor prognosis in the event of a hemorragic stroke, even within its tiny therapeutic window, enzymes do not carry a bleeding risk and prognosis is very good on enzymes.

While warfarin/coumadin actually prevents the first clotting of the natural healing process, which produces that bleeding risk, metabolic enzymes allow the natural healing/clotting process, which stops the bleeding, and then eradicates any excess clotting (and spontaneous blood coagulopathy).

Metabolic enzymes act like and with, and also improve the secretion of, natural plasmin, the body's only fibrinolytic enzyme, while warfarin doesn't even address that the reason for the excessive coagulation is plasmin secretion falling with age in the first place.

BB AllClear is a godsend even compared to the older enzyme blends, which don't contain much or any fibrinolytic enzymes; a diabetic's toes can go from purple to pink in 24-48 hours with BB AllClear; it also excels at eroding existing clots and reducing systemic inflammation that impairs microcirculation, while warfarin doesn't reduce inflammation or erode clots at all.

Goodhealth Naturally encourages comparison between their BlockBuster AllClear and any other blend or single fibrinolytic enzyme on the market; other companies hide their inferior formulas and/or charge twice as much for an obviously inferior product. Neprinol and Wobenzym don't hold a candle to a real fibrinolytic enzyme blend for example.

Make sure you fully understand the huge difference between proteolytic enzymes and fibrinolytic enzymes, and the diff between digestive (food) and empty-stomach (metabolic) enzymes when you try to copy or souce another product. I've done my homework and I think this is the best there is as well as the least expensive, something we don't run into very often.

And it's guraanteed, even the four-month program. I suggest every adult should do a couple of cleanout programs at around 40 and 55 years of age, then go on a low dose to support the falling plasmin levels after around 65 years of age. The low dose would be OK permanently for anyone, especially anyone who wants better microcirculation even in the brain.

The company has many good products. If phoning in your order you get 10% off; PLEASE quote referral ID 1070 in Canada and USA, 1559 in the UK.
Fibrinolytic Enzyme References

The following independent reference material is for educational purposes on this topic and it is not intended be associated with any company's product. No association is made in the research and none is intended.
Amano Enzyme USA Product Information
Application
Products
Form
Opt. pH
Opt. Temp
Specification
Dietary Supplement
α-Galactosidase DS
(Aspergillus niger)
Powder
3.0
60°C
α-Galactosidase activity
10,000 GalU/g(pH 5.5)
Amylase DS
(Aspergillus oryzae)
Powder
5.0
55°C
α-Amylase activity
90,000 DU/g(pH 4.8)
Cellulase DS
(Aspergillus niger)
Powder
4.5
55°C
Cellulase activity
110,000 CU/g(pH 4.5)
Diastase DS
(Barley Malt)
Powder
5.0
55°C
S-Amylase activity
12,000 u/g(pH 5.0)
Lactase 14-DS
(Aspergillus oryzae)
Powder
4.5
55°C
β-Galactosidase activity
14,000 ALU/g(pH 4.5)
Lipase DS
(Rhizopus oryzae)
Powder
6.5
45°C
Lipase activity
12,000 LU/g(pH 6.5)
Lipase F-DS
(Rhizopus oryzae)
Powder
7.0
40°C
Lipase activity
60,000 LU/g(pH 6.5)
NSK-SD (Nattokinase)
(Bacillus subtilis natto)
Powder
7.0
37°C
Nottokinase activity
20,000 FU/g(pH )
Acid Protease DS
(Aspergillus niger)
Powder
3.0
55°C
Protease activity
90,000 HUT/g(pH 4.7)
Protease A-DS
(Aspergillus oryzae)
Powder
7.0
50°C
Protease activity
300,000 HUT/g(pH 4.7)
Protease DS
(Aspergillus melleus)
Powder
8.0
45°C
Protease activity
150,000 HUT/g(pH 4.7)
Phytase DS
(Aspergillus niger)
Powder
5.5
55°C
Phytase activity
3,000 u/g(pH 6.0)
Seaprose S
(Aspergillus melleus)
Powder
8.0
45°C
Proteolytic activity
1,900 u/mg


Duncan Crow HOME

webbed by:Duncan